FIELD: medicine; urology.
SUBSTANCE: albuginea is longitudinal sectioned. Cavernous body is bougienaged, and endoprosthesis is introduced. For this purpose monolithic bio-inert endoprosthesis made of high-pressure polyethylene is used. Endoprosthesis is introduced through section along penis trunk from its base in distal direction to cephalate part of cavernous body. Achieved penis trunk condition is secured by fixation of endoprosthesis to albuginea and auxiliary suture narrowing cavernous body proximally from endoprosthesis end. Patients suffering from Peyronie's disease with preserved autologous erection are introduced with one endoprothesis. In case of evident erection disorder or its absence endoprosthesis of length 1/2-1/3 less of base prosthesis is additionally introduced to opposite cavernous body.
EFFECT: provides simultaneous penis extension; prevents urethra perforation; provides axial stability of penis and reliable prosthesis fixation; operation is low-traumatic; easy to perform; surely provides sexual satisfaction.
3 dwg, 1 ex, 3 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PENILE LENGTHENING AT SURGICAL TREATMENT OF ERECTILE DYSFUNCTION | 2004 |
|
RU2257860C1 |
METHOD FOR SURGICAL THERAPY OF PENILE FIBROPLASTIC INDURATION | 2003 |
|
RU2254818C1 |
METHOD FOR TREATING THE CASES OF SCLEROSED CAVERNOUS BODIES AND FIBROPLASTIC INDURATION OF PENIS | 2002 |
|
RU2217081C1 |
PENIS PROSTHESIS | 1999 |
|
RU2159096C1 |
PENIS PROSTHESIS | 1997 |
|
RU2130761C1 |
METHOD OF SURGICAL TREATMENT OF PEYRONIE'S DISEASE | 2010 |
|
RU2460473C2 |
SURGICAL METHOD FOR MAKING ORGANIC FORM ERECTION DYSFUNCTION CORRECTION CAUSED BY PEIRONI DISEASE | 1999 |
|
RU2179827C2 |
METHOD FOR TREATING PEIRONI DISEASE AND ERECTILE DYSFUNCTION | 2005 |
|
RU2303405C1 |
PENIS PROSTHESIS | 2001 |
|
RU2211007C2 |
METHOD OF SURGICAL TREATMENT OF PEYRONIE'S DISEASE AND ERECTILE DYSFUNCTION | 2008 |
|
RU2376942C1 |
Authors
Dates
2008-06-20—Published
2006-12-07—Filed